This protocol details a method for the dissection of mouse adipose depots and the isolation and digestion of respective arteries to liberate and then identify the endothelial cell population. Freshly isolated cells used in downstream applications will advance the understanding of vascular cell biology and the mechanisms of vascular dysfunction.
Vascular endothelial cells lining the wall of the vascular system play important roles in a variety of physiological processes, including vascular tone regulation, barrier functions, and angiogenesis. Endothelial cell dysfunction is a hallmark predictor and major driver for the progression of severe cardiovascular diseases, yet the underlying mechanisms remain poorly understood. The ability to isolate and perform analyses on endothelial cells from various vascular beds in their native form will give insight into the processes of cardiovascular disease. This protocol presents the procedure for the dissection of mouse subcutaneous and mesenteric adipose tissues, followed by isolation of their respective arterial vasculature. The isolated arteries are then digested using a specific cocktail of digestive enzymes focused on liberating functionally viable endothelial cells. The digested tissue is assessed by flow cytometry analysis using CD31+/CD45− cells as markers for positive endothelial cell identification. Cells can be sorted for immediate downstream functional assays or used to generate primary cell lines. The technique of isolating and digesting arteries from different vascular beds will provide options for researchers to evaluate freshly isolated vascular cells from arteries of interest and allow them to perform a wide range of functional tests on specific cell types.
Endothelial cells are well recognized for their important roles in a variety of physiological processes, including barrier functions, angiogenesis, and vascular tone regulation1,2. Although endothelial cell dysfunction is well documented in promoting atherosclerosis, hypertension, diabetes, etc., the underlying mechanisms driving endothelial dysfunction remain poorly understood and likely differ between distinct vascular beds2,3,4. The effort to unravel these pathological mechanisms of endothelial cell dysfunction is challenged by the limited access to a pure population of endothelial cells from tissues and/or the phenotypic changes of endothelial cells in culture5,6. Therefore, being able to isolate and perform analyses on endothelial cells from various vascular beds in their native form will give insight into the processes of cardiovascular disease.
This protocol presents the procedure to dissect subcutaneous and mesenteric adipose tissues from mice, followed by isolation of their respective arterial vasculature. Functionally viable endothelial cells lining the arterial walls are liberated using a specific cocktail of enzymes. Special care was taken to optimize the conditions of the digestion protocol to obtain a sufficient yield of endothelial cells from <1 mg of starting tissue while keeping biomolecular markers intact for analysis. Isolated endothelial cells are next identified using flow cytometry. The presence of CD31 (PECAM) is used to primarily identify endothelial cells. Due to the expression of CD31 in other cell types, including several of hematopoietic origin that also express CD45, the purity of the isolated endothelial cells was further enhanced by the exclusion of cells expressing both CD31 and CD455,6,7,8. Moreover, depending on the research question and the downstream applications to be employed, researchers should consider selecting an extensive panel of positive and negative selection markers to optimize the purity of the cell population of interest.
Though the technique of dissecting and isolating adipose depot arteries has been used in the previous publications9,10,11,12,13, a detailed protocol describing the isolation of embedded arteries has yet to be presented. Demonstrating the technique for the isolation and digestion of arteries from different vascular beds from a given species of interest will provide options for researchers to evaluate freshly isolated vascular cells from arteries of interest and allow them to perform a wide range of functional tests on specific cell types. Tests may include but are not limited to flow cytometry for cell sorting and membrane protein expression5,8, electrophysiology for ion channel activity9, molecular profiling (proteomics/genomic analyses, etc.)14,15, and the generation of primary cell lines for drug screening in vitro16,17.
The use of animals in these studies was approved by the University of Delaware, Institutional Animal Care and Use Committee (#1372).
1. Tissue dissection and cleaning
NOTE: 10- to 12-week-old C57BL/6J mice are used in the video protocol. Please refer to Figure 1 for the schematic and the desired outcome of tissue dissection and cleaning arteries and refer to the Table of Materials for the list of supplies and manufacturer information.
2. Digestion of isolated arteries for isolation of endothelial cells
NOTE: Please refer to Figure 2 for the schematic of tissue digestion and isolation of endothelial cells and the Table of Materials for a complete list of supplies needed for the protocol.
3. Staining of endothelial cells prior to flow cytometry
NOTE: The staining and processing of endothelial cells are carried out on ice to improve cell viability, unless instructed. The 5 mL polystyrene round-bottom tubes are centrifuged at 1,163 x g for 3 min at room temperature (RT).
A schematic of the workflow is shown in Figure 1. The schematic highlights the protocol steps described in more detail in the protocol text. Figure 2 shows pictures of subcutaneous adipose (Figure 2A, left) following dissection and a subcutaneous artery arcade (Figure 2A, right) following cleaning of the parenchymal tissue. Figure 2 also shows the mesenteric adipose (Figure 2B, left) following dissection and the mesenteric arterial arcade (Figure 2B, right) following cleaning of the parenchymal tissue.
The protocol presented here is designed to assist researchers potentially interested in a) comparing distinct adipose depot vasculature beds in basic science approaches and/or disease models, b) the digestion of vascular beds prior to isolation of vascular cells of interest for downstream application, and c) the use of flow cytometry to identify vascular cells of interest (Figure 3) for a variety of applications including, but not limited to, protein expression analyses as performed here (Figure 4). Figure 3 details an example of our approach to identify endothelial cells from digested mouse arteries using flow cytometry. Cell preparations obtained from digested subcutaneous (Figure 3A) or mesenteric (Figure 3B) adipose arteries were stained with CD31-PE, CD45-FITC, and a cell viability dye prior to the fixation and identification of viable CD31+CD45− endothelial cells using flow cytometry, as similarly performed elsewhere8. The cell viability stain allowed for the identification of only those viable cells that survived the isolation and digestion protocol prior to fixation. The use of this method will allow researchers to assess the expression or function of viable vascular cells of interest.
To determine if endothelial cells isolated from distinct adipose depot vasculature exhibited differences in membrane protein expression, isolated cells were probed for the fatty acid translocase, CD36 (Figure 4), as this membrane protein was recently shown to be essential in the endothelial-mediated distribution of fatty acids to tissues22. Therefore, determining the relative expression differences between membrane CD36, for example, in distinct vascular beds may a) support existing data regarding differential preference for fatty acid utilization among different tissues and/or b) unveil potential novel differences in tissue distribution of fatty acids in health and disease. From the same preparations of digested vascular cells exemplified in Figure 3, CD31+CD45−CD36+ endothelial cells were identified in subcutaneous (Figure 4A) and mesenteric (Figure 4B) adipose, and CD36 expression was quantified in this population in each vascular bed. Figure 4C and Figure 4D reveal that both the percentage of endothelial cells expressing CD36 and the intensity of CD36 expression were greater in subcutaneous endothelial cells compared to that observed in mesenteric endothelial cells. These preliminary findings support the use of our methodology to identify distinct differences between vascular beds.
Figure 1: Working scheme to isolate endothelial cells from subcutaneous and visceral adipose tissues for downstream applications. (A)10-12-week-old C57BL/6J mice were euthanized and used to demonstrate this procedure. (Bi) First, the subcutaneous adipose is removed. (Bii) Then, the mesenteric (visceral) adipose tissue is subsequently removed. The white dashed lines indicate the locations of the subcutaneous (left) and mesenteric (right) adipose depots following the dissection and removal. The respective arteries are isolated for downstream applications. (C) In this protocol, isolated arteries are next digested using a specific enzyme cocktail as a first step in liberating functionally viable endothelial cells. (D) Isolated endothelial cells are identified by probing for CD31+ and CD45− cells using conjugated antibodies prior to flow cytometry analysis. Cells with an expression profile of CD31+/CD45− are the endothelial cells of interest for additional analyses. Please click here to view a larger version of this figure.
Figure 2: Isolated subcutaneous and visceral adipose tissues and respective arteries. (A) Left: Isolated "C-shaped" subcutaneous adipose tissue from hindlimbs. A major branch of the subcutaneous adipose artery, denoted by arrow (1), is revealed when parenchymal adipose is removed. Right: Isolated subcutaneous adipose arteries. (B) Left: The mesenteric (visceral) adipose tissue is isolated from the gut. Right: The respective arterial arcade is isolated by removing the parenchymal tissue. Different scales are used between the pictures of adipose (5 mm) and arteries (1 mm). Please click here to view a larger version of this figure.
Figure 3: Identification of endothelial cells following arterial tissue digestion via flow cytometry. Representative plots showing cells liberated from isolated (A) subcutaneous or (B) mesenteric adipose arteries. Cells were exposed to conjugated antibodies that targeted extracellular epitopes of CD31 (PE) and CD45 (FITC) prior to fixation. Flow cytometry was used to identify the CD31+CD45− endothelial cell population. A cell viability stain was used to select only the cells that survived the isolation and digestion protocols for subsequent analyses. In addition, appropriate gating at this stage will further separate an intended cell population from contaminating cells should the size of the cell type of interest be known. Please click here to view a larger version of this figure.
Figure 4: Analysis of CD36 membrane expression in subcutaneous vs. mesenteric adipose artery endothelial cells via flow cytometry. Representative population plots and histograms showing endothelial CD36 (APC) membrane expression in (A) subcutaneous or (B) mesenteric adipose arteries. (C) Percentage of endothelial cells (ECs) expressing CD36 in subcutaneous vs. mesenteric ECs (n = 5, 3 males, 2 females; *p < 0.05 following Student's t-test). (D) Normalized EC membrane CD36 expression in subcutaneous vs. mesenteric adipose arteries (n = 5, 3 males, 2 females; *p < 0.05 following Student's t-test). Please click here to view a larger version of this figure.
Endothelial dysfunction is a precursor to severe disease states, likely driving the development of atherosclerosis, hypertension, and stroke3,23. While the identified mechanisms underlying endothelial dysfunction in a given pathological condition are many, distinct vascular beds are likely to be differentially influenced by pathological conditions4,24. Furthermore, different cardiovascular risk factors (e.g., obesity, hypertension, dyslipidemia, smoking, diabetes) induce dysfunction through a variety of distinct mechanisms23,25. Therefore, it is critical to isolate endothelial cell populations from established animal models of disease or accessible human tissue and perform assays on cells immediately removed from the in vivo environment. Isolating cells in this way has a unique advantage over studying cells in culture in that they are void of culture-induced phenotypic changes5,6. Moreover, including a heterogenous endothelial cell population, as observed in vivo26,27 (and that can be further separated using flow-assisted cell sorting), from a live organism better informs the in vivo environment. Finally, this method is applicable to the investigation of numerous animal models and potentially human tissue and can be used to generate primary cell culture lines, if such a need is warranted.
The critical step in this protocol, and the step that will need most adjusting for different vascular beds or cell types not presented here, is the digestion of vascular tissue. This step must be optimized for cell health without diminishing cell yield. The specific enzymes used and the duration for digestion are critical to optimizing cell health and yield to be able to adequately perform downstream assays. For the identification of membrane expression of CD36, as detected by flow cytometry in subcutaneous and mesenteric endothelial cells (Figure 4), a modified version of the digestion protocol originally designed for patch-clamp electrophysiology28 was developed. This included an extension of the collagenase I digestion time to 30 min to increase cell yields to better meet the demands of flow cytometry vs. what is required for patch-clamp studies. As this modification may impact cell health to some extent, a cell viability stain was used in the flow cytometry analyses to ensure that only viable endothelial cells were assessed following this protocol (Figure 3). It is recommended that studies aimed at isolating cells from vascular tissue should include a marker for cell viability prior to assessing the desired approach.
The described protocol is sufficient to liberate viable endothelial cells for analysis and downstream applications from ≤1 mg arterial samples derived from mice; however, if the arteries of interest were to be isolated from different tissues or organisms (e.g., humans) that would result in significantly different arterial masses, one would have to optimize the digestion enzyme content and the duration of incubation to efficiently isolate the cell population of interest. For some vascular beds that begin with even smaller amounts of starting tissue than the subcutaneous and mesenteric beds presented here (e.g., coronary arteries), pooling of arteries from several mice may be necessary per sample. Indeed, this may be a necessary step for any given vascular bed given that the outcome approach requires a relatively high cell yield. A major limitation is that, due to the nature of variations per sample digestion, cell yields can sometimes be significantly different across batches even when from the same vascular bed. This can cause issues when analyzing data and should be accounted for via normalization when appropriate. For instance, CD36 expression was extremely variable in the raw data due to alterations in cell yields across individual samples of subcutaneous and mesenteric adipose arteries. Therefore, raw data was normalized to CD31+CD45− mean fluorescence intensity with the assumption that this method would correct for batch differences (Figure 4). Of course, depending on the approach, more sophisticated statistical analyses and normalization methods may be required.
In summary, this paper presents a method to dissect, isolate, and digest subcutaneous and mesenteric arteries from mice to investigate the expression and/or function of endothelial targets of interest. With modifications to the presented protocol, different vascular beds and cell types (e.g., smooth muscle cells) can be investigated. This protocol, as a foundation for a plethora of available experimental approaches, has the potential to advance the understanding of vascular cell biology and mechanisms of vascular dysfunction.
The authors have nothing to disclose.
In loving memory of Rich West, a brilliant scientist, colleague, and dear friend. We would like to thank the University of Delaware Flow Cytometry and BioImaging Core as part of the Delaware Biotechnology Institute for their ongoing contributions to our studies. We would also like to thank Emma Hudgins for the careful review and editing of the manuscript. Our work is supported by the National Institute of General Medical Sciences P20GM113125-6564 (I.S. Fancher). This project was also supported by the Delaware INBRE program, with a grant from the NIGMS (P20GM103446) from the National Institutes of Health and the State of Delaware (I.S. Fancher), and a University of Delaware General University Research grant (I.S. Fancher). This content is solely the responsibility of the authors and does not necessarily represent the official views of NIH.
Tissue dissection tools | |||
5 forceps (2) | Fine Science Tools | 11252-00 | For isolation of mesenteric adipose depot and arteries transfer |
55 forceps (2) | Fine Science Tools | 11295-51 | For parenchymal adipose removal |
Curved Bonn scissors | Fine Science Tools | 14061-10 | For isolation of mesenteric adipose depot |
Graefe forceps | Fine Science Tools | 11051-10 | For general dissection steps and isolation of subcutaneous adipose depot |
Straight Bonn scissor | Fine Science Tools | 14060-09 | For general dissection steps and isolation of subcutaneous adipose depot |
Stereoscope with light source | Laxco | Z230PT40 | For parenchymal adipose removal and artery isolation |
Digestive enzymes for Artery Digestion | |||
Collagenase Type I | Wothington-BioChem | LS004194 | |
Dispase (Neutral Protease) | Wothington-BioChem | LS02110 | |
Elastase | Wothington-BioChem | LS002292 | |
Solutions Recipes | |||
HEPES Buffer, pH 7.4 | Final concentration | ||
Calcium chloride dihydrate | J.T.Baker | 1332-1 | 2 mM |
Dextrose (D-glucose) anhydrous | Fisher | D16-500 | 10 mM |
HEPES | Fisher | BP310-500 | 10 mM |
Magnesium Chloride | Fisher | M33-500 | 1 mM |
Potassium Chloride | Fisher | P217-500 | 5 mM |
Sodium chloride | Oxoid | LP0005 | 145 mM |
Dissociation Solution, pH 7.30-7.40 | |||
Dextrose (D-glucose) anhydrous | Fisher | D16-500 | 10 mM |
HEPES | Fisher | BP310-500 | 10 mM |
Magnesium Chloride | Fisher | M33-500 | 2 mM |
Potassium Chloride | Fisher | P217-500 | 56 mM |
Sodium chloride | Oxoid | LP0005 | 55 mM |
Sodium L-Glutamate monohydrate | TCI | G0188 | 80 mM |
Flow Cytometry Analyses | |||
5 mL Polystyrene round-bottom tube with cell-strainer cap | Falcon | 352235 | |
CD31-PE | Miltenyi Biotec | 130-119-653 | 0.75µg/sample |
CD36-APC | R&D Systems | AF2519 | 2.5µg/ sample |
CD45-FITC | BioLegend | 103108 | 2.5µg/ sample |
Live/Dead Fixable Violet Dead Cell Staining kit (cell viability stain) | Invitrogen | L34955 | 1µL/sample |